Other findings have highlighted the link between TPC1 expression dysregulation and tumorigenicity, demonstrating that TPC1 transcripts were approximately three to eightfold higher than TPC2 ones in the SKBR3 human breast cancer cell line (Brailoiu et al., 2009). This evidence concerns the gene TPCN1 and breast carcinoma.